Onkologic Inc. offers novel cell culture media products for Natural Killer (NK) cell immunotherapy. Developed under the aegis of an NIH grant, Enable-NK media supports enhanced performance and quality of expanded NK cells for research and clinical use.

Fee-for-service entity facilitating life sciences innovations and product development● Drug and biologic formulations, drug-device combination products, medical devices● Cancer Immunotherapy cell-culture assays for immune cell activation characterization● R&D Project Management, External Innovation, Technology and Product Development● Ideating, Brainstorming, Prototyping, and Intellectual Property (IP) creation● Pre-clinical study design and execution● Clinical study… Show more Fee-for-service entity facilitating life sciences innovations and product development● Drug and biologic formulations, drug-device combination products, medical devices● Cancer Immunotherapy cell-culture assays for immune cell activation characterization● R&D Project Management, External Innovation, Technology and Product Development● Ideating, Brainstorming, Prototyping, and Intellectual Property (IP) creation● Pre-clinical study design and execution● Clinical study design, statistical analysis● Regulatory strategy● Licensing and M&A Support Show less

● Built multi-disciplinary team and microsphere platform technology from scratch ● Led Technology Development efforts for Pain Management and Interventional Oncology (IO)● Drove Voice of Customer (VoC) with Key Opinion Leader (KOL) physicians and surgeons● Nurtured several external collaborations (e.g. Harvard Medical School) ● Delivered successful technical and program outcomes for product development and commercialization